Free Trial

Phathom Pharmaceuticals (PHAT) SEC Filings & 10K Form

$10.50
+0.20 (+1.94%)
(As of 05/24/2024 04:00 PM ET)

Recent Phathom Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/24/2024
6:33 PM
KARBE FRANK (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:43 PM
FIELDS HEIDI (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:44 PM
COLA MICHAEL F (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:46 PM
Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:47 PM
Phathom Pharmaceuticals (Issuer)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:14 PM
Phathom Pharmaceuticals (Issuer)
Socks David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:18 PM
Phathom Pharmaceuticals (Issuer)
Stenhouse Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
3:03 PM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
3:30 PM
Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
5:10 AM
Phathom Pharmaceuticals (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
Form SC 13D/A
04/01/2024
5:15 AM
Phathom Pharmaceuticals (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
Form SC 13D/A
03/26/2024
3:05 PM
Curran Terrie (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
7:06 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/26/2024
3:00 PM
Phathom Pharmaceuticals (Subject)
Form SC 13G/A
01/26/2024
3:00 PM
Medicxi Growth I LP (Filed by)
Phathom Pharmaceuticals (Subject)
Form SC 13G/A
01/25/2024
5:13 AM
Phathom Pharmaceuticals (Issuer)
TAKEDA PHARMACEUTICAL CO LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
5:11 AM
Phathom Pharmaceuticals (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
Form SC 13D/A
01/22/2024
7:19 PM
Curran Terrie (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
7:21 PM
Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
7:22 PM
Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2023
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2023
7:06 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2023
3:40 PM
Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2023
11:15 PM
Phathom Pharmaceuticals (Filer)
Form EFFECT
11/09/2023
3:02 PM
Phathom Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/09/2023
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2023
6:56 PM
Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
3:53 PM
Curran Terrie (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
3:54 PM
Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
3:55 PM
Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2023
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2023
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2023
7:07 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2023
7:06 AM
Phathom Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/21/2023
7:30 PM
Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4/A
07/17/2023
4:00 PM
Nabulsi Azmi (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2023
4:00 PM
Curran Terrie (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Nvidia’s Quiet $1 Trillion Pivot (Ad)

Nvidia recently added $277 billion in market cap … IN ONE DAY.

Find out details on these three critical Nvidia partners immediately.
07/17/2023
4:00 PM
Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2023
3:02 PM
Phathom Pharmaceuticals (Subject)
Form SC TO-I/A
07/17/2023
3:04 PM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2023
8:10 AM
Phathom Pharmaceuticals (Subject)
Form SC TO-C
06/15/2023
8:01 AM
Phathom Pharmaceuticals (Subject)
Form SC TO-I
06/15/2023
8:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2023
7:05 AM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2023
5:32 PM
Henderson Molly (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
5:37 PM
Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
5:46 PM
COLA MICHAEL F (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
5:48 PM
KARBE FRANK (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
5:53 PM
FIELDS HEIDI (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
5:55 PM
Parikh Asit (Reporting)
Phathom Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
5:57 PM
Phathom Pharmaceuticals (Issuer)
Socks David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
6:01 PM
Phathom Pharmaceuticals (Issuer)
Stenhouse Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
6:03 PM
Phathom Pharmaceuticals (Issuer)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
4:16 PM
Phathom Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:PHAT) was last updated on 5/27/2024 by MarketBeat.com Staff

From Our Partners